Compare Sana Biotechnology Inc (SANA) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs United States Oil ETF — how do they compare? Sana Biotechnology Inc trades at $3.2 (market cap $873.84M), while United States Oil ETF trades at $129.76. The key difference: United States Oil ETF is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | USO | |
|---|---|---|
Market Cap | $873.84M | — |
Sector | Health | — |
52-Week High | $5.92 | $152.96 |
52-Week Low | $2.68 | $66.17 |
Enterprise Value | $848.03M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $3.14, down 0.32% with a bearish technical signal. The company shows negative profitability metrics with ROE at -147.41% and net income of -$244.17M for 2025, though cash burn is projected to improve significantly in 2026. Recent positive developments include NEJM publication of groundbreaking diabetes data and multiple conference presentations highlighting clinical progress.
While analyst sentiment remains strongly bullish (82% buy ratings), the stock faces fundamental challenges with significant losses and high P/B ratio of 7.33. Investment opportunity lies in clinical pipeline advancements, but risks include ongoing cash burn and execution challenges in bringing therapies to market.
USO trades at $125.51, up 1.25% with a bullish technical signal driven by moving averages. Recent news highlights Middle East supply disruptions as a key catalyst, with oil prices testing resistance levels. The stock shows strong momentum but overbought RSI readings suggest caution near-term.
Outlook remains positive given geopolitical tensions supporting oil prices, though elevated RSI indicates potential pullback risk. Key support sits at $124, with resistance at $127. Investors face volatility from supply shocks and inflation concerns, requiring careful position management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
